ÉTUDE PRODIGE 18-UNICANCER-Accord22 - Recrutement terminé/clôturé
Title
Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab
Coordonateur
BENNOUNA J
Co-Coordonateur
HEBBAR M
Promoteur
UNICANCER (UCGI)Localisation
Cancer Colorectal Métastatique
Phase
IIR
NOMBRE DE PATIENTS ATTENDU
132
Statut
Recrutement terminé/clôturé
CONTACT
c-dumasbonnetain@unicancer.fr